Please use this identifier to cite or link to this item: http://hdl.handle.net/1783.1/6920

Plasma or serum marker and process for detection of cancer

Authors Hsiao, W. L. Wendy
Wong, Sze Chuen
Issue Date 2010-10-12
Source US Patent 7,811,752 B2, 2010
Summary This disclosures provides, in one aspect, a method for detecting non-clinically diagnosed cancer in a patient. In one embodiment, the method includes extracting blood serum or plasma from the patient, and then detecting beta-catenin RNA in the blood serum or plasma. In addition, in this embodiment, the method includes determining the presence of the cancer based on the detected beta-catenin RNA. In another aspect, this disclosure provides another embodiment of a method for detecting non-clinically diagnosed cancer in a patient. In this embodiment, the method includes extracting blood serum or plasma from the patient, and then detecting beta-catenin DNA in the blood serum or plasma. In addition, in this embodiment, the method includes determining the presence of the cancer based on the detected beta-catenin DNA. Related methods for detecting non-clinically diagnosed cancer in a patient comprising detecting beta-catenin-associated gene RNA, and beta-catenin-associated gene DNA, in the blood serum or plasma are also disclosed.
Subjects
Rights This patent is also available at HKUST Technology Transfer Center Patent Search at <http://patentsearch.ttc.ust.hk/ListPatentsDetail.asp?id=287>
Language English
Format Patent
Access
Files in this item:
File Description Size Format
US7811752.pdf 1597691 B Adobe PDF